Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.
about
MiR-339 depresses cell proliferation via directly targeting S-phase kinase-associated protein 2 mRNA in lung cancer.S-phase kinase-associated protein 2 is involved in epithelial-mesenchymal transition in methotrexate-resistant osteosarcoma cells.F-box proteins involved in cancer-associated drug resistance.
P2860
Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.
@en
Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.
@nl
type
label
Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.
@en
Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.
@nl
prefLabel
Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.
@en
Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.
@nl
P2093
P2860
P356
P1476
Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.
@en
P2093
Guanggui Ding
Guangsuo Wang
Tonghai Huang
Zheng Wang
P2860
P304
P356
10.2147/OTT.S125789
P407
P577
2017-01-18T00:00:00Z